Abstract
The concentration-EEG effect relationship of midazolam in the rat was studied from a population perspective. Plasma concentration and EEG effect data from 27 rats were available for analysis. Effect parameters derived from aperiodic EEG analysis were used as effect parameters. The population analysis gave results that were similar to the sample theory estimates (¯xs and SDs) obtained from the fits to individual data sets. Reanalysis of the EEG data using mean population pharmacokinetic parameters as input to the pharmacodynamic model led to poorer estimation of the pharmacodynamic parameters: particularly EC50.Inclusion of one observed plasma concentration per individual significantly improved the estimation of the pharmacodynamic parameters and led to results that were virtually indistinguishable from those obtained using complete pharmacokinetic data.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Measurement and kinetics ofin vivo drug effects. IUPHAR Satellite Symposium, Noordwijk, The Netherlands, 1990.
N. H. G. Holford and L. B. Sheiner. Kinetics of pharmacologic response.Pharmacol. Ther. 16:143–166 (1982).
R. Koopmans, J. Dingemanse, M. Danhof, G. P. M. Horsten, and C. J. Boxtel. Pharmacokinetic-pharmacodynamic modeling of midazolam effects on the human central nervous system.Clin. Pharmacol. Ther. 44:14–22 (1988).
D. J. Greenblatt, B. L. Ehrenberg, J. Gunderman, A. Locniskar, J. M. Scavone, J. S. Harmatz, and R. I. Shader. Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam and placebo.Clin. Pharmacol. Ther. 45:356–365 (1989).
L. T. M. Breimer, P. J. Hennis, A. G. L. Burm, M. Danhof, J. G. Bovill, J. Spierdijk, and A. A. Vierter. Quantification of the EEG effect of midazolam by aperiodic analysis in volunteers. Pharmacokinetic/pharmacodynamic modelling.Clin. Pharmacokin. 18:245–253 (1990).
J. W. Mandema, E. Tukker, and M. Danhof. Pharmacokinetic-pharmacodynamic modelling of the EEG effects of midazolam in individual rats: influence of rate and route of administration.Br. J. Pharmacol. 102:663–668 (1991).
J. W. Mandema, L. N. Sansom, M. C. Dios-Vieitez, M. Hollander-Jansen, and M. Danhof. Pharmacokinetic-pharmacodynamic modelling of the EEG effects of benzodiazepines. Correlation with receptor binding and anticonvulsant activity.J. Pharmacol. Exp. Ther. 257:472–478 (1991).
T. K. Gregory and D. C. Pettus. An electroencephalographic processing algorithm specifically intended for analysis of cerebral electrical activity.J. Clin. Monit. 2:190–197 (1986).
J. W. Mandema and M. Danhof. Pharmacokinetic-pharmacodynamic modelling of the CNS effects of heptabarbital using aperiodic EEG analysis.J. Pharmacokin. Biopharm. 18:459–482 (1990).
S. L. Beal and L. B. Sheiner.NONMEM User's Guide, Division of Clinical Pharmacology, University of California, San Francisco, 1979.
L. B. Sheiner and S. L. Beal. Bayesian individualisation of pharmacokinetics: simple implementation and comparison with non-Bayesian methods.J. Pharm. Sci. 71:1344–1348 (1982).
L. Endrenyi. Design of experiments for estimating enzyme and pharmacokinetic parameters. In L. Endrenyi (ed.),Kinetic Data Analysis, Plenum Press, New York, 1981, pp. 136–167.
Author information
Authors and Affiliations
Additional information
This study was supported by Medigon grant 900-521-106.
Rights and permissions
About this article
Cite this article
Aarons, L., Mandema, J.W. & Danhof, M. A population analysis of the pharmacokinetics and pharmacodynamics of midazolam in the rat. Journal of Pharmacokinetics and Biopharmaceutics 19, 485–496 (1991). https://doi.org/10.1007/BF01062959
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01062959